Keijiro Saku1, Bo Zhang, Keita Noda. Show Affiliations » 1. Department of Cardiology, Fukuoka University School of Medicine, Japan.
Abstract
Entities: Chemical
Mesh: See more » AtorvastatinCholesterol, LDL/bloodFluorobenzenes/adverse effectsFluorobenzenes/therapeutic useHeptanoic Acids/adverse effectsHeptanoic Acids/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypercholesterolemia/drug therapyPyrimidines/adverse effectsPyrimidines/therapeutic usePyrroles/adverse effectsPyrroles/therapeutic useQuinolines/adverse effectsQuinolines/therapeutic useRosuvastatin CalciumSulfonamides/adverse effectsSulfonamides/therapeutic use
Substances: See more » Cholesterol, LDLFluorobenzenesHeptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsPyrimidinesPyrrolesQuinolinesSulfonamidesRosuvastatin CalciumAtorvastatinpitavastatin
Year: 2011 PMID: 22338904 DOI: 10.2169/naika.100.3679
Source DB: PubMed Journal: Nihon Naika Gakkai Zasshi ISSN: 0021-5384